Sanara MedTech Board Evolution with Strategic New Appointment
Company Announcements

Sanara MedTech Board Evolution with Strategic New Appointment

An announcement from Sanara MedTech ( (SMTI) ) is now available.

Sanara MedTech Inc. announced significant changes to its Board of Directors with the resignation of long-serving director James “Jim” Stuckert, who will remain as Director Emeritus, and the appointment of Keith Myers, an esteemed figure in the home health industry. Myers, recognized for his leadership and contributions to healthcare policy, will bring his strategic vision and experience to Sanara’s next growth phase. His appointment is expected to bolster the company’s expertise as it continues to advance in the surgical, chronic wound, and skincare markets.

Find detailed analytics on SMTI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySanara MedTech reports Q3 EPS (34c) vs (13c) last year
Christine BrownIs SMTI a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App